ipilimumab
bms
['melanoma', 'ipilimumab']
treatment with tumor-infiltrating
lymphocytes (til) ipilimumab for advanced melanoma bu dr. j haanen 80% received prior io study met pfs endpoint! 20% cr &gt;g3+ aes almost all patients! #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni